Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 09:22:12 +0200Fri, 12 Jul 2024 13:00:00 +0200Human medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of authorisation: 28/06/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/altuvoctHuman medicines European public assessment report (EPAR): Altuvoct, efanesoctocog alfa, Date of authorisation: 28/06/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/altuvoctFri, 12 Jul 2024 13:00:00 +0200Human medicineAltuvoct : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5968-en.pdfAltuvoct : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5968-en.pdfFri, 12 Jul 2024 11:11:01 +0200Human medicine